Implication for health policy/practice/research/medical education:
Eprex an erythropoietin analogue is a promising renoprotective drug to prevent or attenuate GM-induced tubular damage and introduces a novel therapeutic strategy for patients with renal tubular epithelial cell damage. However, there are still needs for studies on the mechanisms which are involved in these protective actions.
Please cite this paper as: Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology. 2012; 1(2): 81-82. DOI: 10.5812/nephropathol.7475